ResMed Inc.
252.86USD
-0.2000 (-0.08%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on RMD.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.67▼ | $2.83 | 0 | 1 |
| Next quarter | $3.02▲ | $3.01 | 0 | 1 |
| Current year | $12.09▲ | $11.95 | 0 | 2 |
| Next year | $13.26▲ | $13.03 | 3 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.89 | $2.95 | +0.06 (+2.0%) |
| 2026-03-31 | $2.8 | $2.86 | +0.06 (+2.1%) |
| 2025-12-31 | $2.72 | $2.81 | +0.09 (+3.2%) |
| 2025-09-30 | $2.5 | $2.55 | +0.05 (+2.1%) |
222 ratings from 31 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Upgraded from Sector Perform | Outperform | $244 $262 | Sep 15, 2026 |
| Keybanc | Maintained | Overweight | $255 $267 | Aug 31, 2026 |
| Rothschild & Co | Initiated | Neutral | $230 | Aug 19, 2026 |
| RBC Capital | Maintained | Sector Perform | $234 $244 | Aug 7, 2026 |
| Piper Sandler | Maintained | Neutral | $233 $225 | Aug 7, 2026 |
| Keybanc | Maintained | Overweight | $260 $255 | Aug 7, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $225 $215 | Aug 7, 2026 |
| Mizuho | Maintained | Outperform | $235 $220 | Jul 15, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $270 $235 | Jul 13, 2026 |
| Jefferies | Maintained | Hold | $240 $225 | Jul 10, 2026 |
| RBC Capital | Maintained | Outperform | $321 $276 | Jul 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $227 $225 | Jul 8, 2026 |
| Keybanc | Maintained | Overweight | $290 $266 | Jun 22, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $286 $230 | Jun 17, 2026 |
| Citigroup | Maintained | Buy | $340 $270 | Jun 15, 2026 |
| RBC Capital | Maintained | Outperform | $314 $321 | May 1, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $270 $227 | May 1, 2026 |
| Keybanc | Maintained | Overweight | $302 $290 | Apr 27, 2026 |
| Citigroup | Maintained | Buy | $345 $340 | Apr 9, 2026 |
| Citigroup | Maintained | Buy | $330 $345 | Feb 2, 2026 |
| RBC Capital | Maintained | Outperform | $311 $314 | Jan 30, 2026 |
| Piper Sandler | Maintained | Neutral | $270 $275 | Jan 30, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $265 $270 | Jan 30, 2026 |
| Stifel | Maintained | Hold | $260 $265 | Jan 30, 2026 |
| Stifel | Maintained | Hold | $270 $260 | Dec 18, 2025 |
157 filings from 22 insiders · 7 buy / 6 sell over 6m
Officers and directors of RMD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Farrell Michael J.Director; Officer, Chairman and CEO | ExerciseResMed Common Stock Options | 5.0k | — | — | Oct 7, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | Sell | 5.0k | $226.33 | $1.13M | Oct 7, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | Exercise | 5.0k | $146.34 | $730k | Oct 7, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | ExerciseResMed Common Stock Options | 5.0k | — | — | Sep 8, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | Sell | 5.0k | $222.44 | $1.11M | Sep 8, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | Exercise | 5.0k | $146.34 | $730k | Sep 8, 2026 |
| FARRELL PETER CDirector | Sell | 970 | $234.73 | $228k | Sep 2, 2026 |
| Leong JustinOfficer, Chief Product Officer | Grant | 6.5k | — | — | Aug 14, 2026 |
| Rider Michael JOfficer, Global General Counsel | Grant | 3.2k | — | — | Aug 14, 2026 |
| Farrell Michael J.Director; Officer, Chairman and CEO | Grant | 13.5k | — | — | Aug 14, 2026 |
| Bloomer AaronOfficer, Chief Financial Officer | Grant | 9.1k | — | — | Aug 14, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Sell | 5.0k | $205.69 | $1.03M | Aug 7, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Exercise | 5.0k | $146.34 | $730k | Aug 7, 2026 |
| FARRELL PETER CRAIGDirector | Sell | 8.0k | $225.00 | $1.80M | Aug 5, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Sell | 5.0k | $193.96 | $968k | Jun 8, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Exercise | 5.0k | $146.34 | $730k | Jun 8, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Sell | 5.0k | $207.82 | $1.04M | May 7, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Exercise | 5.0k | $146.34 | $730k | May 7, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Sell | 5.0k | $225.50 | $1.13M | Apr 7, 2026 |
| FARRELL MICHAEL JChief Executive Officer | Exercise | 5.0k | $146.34 | $730k | Apr 7, 2026 |
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 7 | 10 | 1 | 0 | Hold2.50 |
| 1 mo ago | 2 | 7 | 10 | 1 | 0 | Hold2.50 |
| 2 mo ago | 1 | 7 | 11 | 1 | 0 | Hold2.60 |
| 3 mo ago | 1 | 6 | 10 | 1 | 0 | Hold2.61 |
Members whose judged calls on RMD have played out most reliably.
No settled calls on RMD yet. 1 call is open, the first due Oct 23, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice